Literature DB >> 29995732

Frequency of Opioid Dispensing After Vaginal Delivery.

Malavika Prabhu1, Elizabeth M Garry, Sonia Hernandez-Diaz, Sarah C MacDonald, Krista F Huybrechts, Brian T Bateman.   

Abstract

OBJECTIVE: To describe nationwide patterns in outpatient opioid dispensing after vaginal delivery.
METHODS: Using the Truven Health Analytics MarketScan database, we performed a large, nationwide retrospective cohort study of commercially insured beneficiaries who underwent vaginal delivery between 2003 and 2015 and who were opioid-naive for 12 weeks before the delivery admission. We assessed the proportion of women dispensed an oral opioid within 1 week of discharge, the associated median oral morphine milligram equivalent dose dispensed, and the frequency of opioid refills during the 6 weeks after discharge. We evaluated predictors of opioid dispensing using multivariable logistic regression.
RESULTS: Among 1,345,244 women undergoing vaginal delivery, 28.5% were dispensed an opioid within 1 week of discharge. The most commonly dispensed opioids were hydrocodone (44.7%), oxycodone (34.6%), and codeine (13.1%). The odds of filling an opioid were higher among those using benzodiazepines (adjusted odds ratio [OR] 1.87, 95% CI 1.73-2.02) and antidepressants (adjusted OR 1.63, 95% CI 1.59-1.66), smokers (adjusted OR 1.44, 95% CI 1.38-1.51), and among those undergoing tubal ligation (adjusted OR 3.77, 95% CI 3.67-3.87), operative vaginal delivery (adjusted OR 1.52, 95% CI 1.49-1.54), and higher order perineal laceration (adjusted OR 2.15, 95% CI 2.11-2.18). The median (interquartile range, 10th-90th percentile) dose of opioids dispensed was 150 (113-225, 80-345) morphine milligram equivalents, equivalent to 20 tablets (interquartile range 15-30, 10th-90th percentile 11-46) of 5 mg oxycodone. Six weeks after discharge, 8.5% of women filled one or more additional opioid prescriptions.
CONCLUSION: Opioid dispensing after vaginal delivery is common and often occurs at high doses. Given the frequency of vaginal delivery, this may represent an important source of overprescription of opioids in the United States.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29995732      PMCID: PMC6060020          DOI: 10.1097/AOG.0000000000002741

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  14 in total

1.  Transparency and Reproducibility of Observational Cohort Studies Using Large Healthcare Databases.

Authors:  S V Wang; P Verpillat; J A Rassen; A Patrick; E M Garry; D B Bartels
Journal:  Clin Pharmacol Ther       Date:  2016-03       Impact factor: 6.875

2.  Medication Sharing, Storage, and Disposal Practices for Opioid Medications Among US Adults.

Authors:  Alene Kennedy-Hendricks; Andrea Gielen; Eileen McDonald; Emma E McGinty; Wendy Shields; Colleen L Barry
Journal:  JAMA Intern Med       Date:  2016-07-01       Impact factor: 21.873

3.  Births: Final Data for 2015.

Authors:  Joyce A Martin; Brady E Hamilton; Michelle J K Osterman; Anne K Driscoll; T J Mathews
Journal:  Natl Vital Stat Rep       Date:  2017-01

4.  CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016.

Authors:  Deborah Dowell; Tamara M Haegerich; Roger Chou
Journal:  MMWR Recomm Rep       Date:  2016-03-18

5.  Postpartum venous thromboembolism: incidence and risk factors.

Authors:  Naomi K Tepper; Sheree L Boulet; Maura K Whiteman; Michael Monsour; Polly A Marchbanks; W Craig Hooper; Kathryn M Curtis
Journal:  Obstet Gynecol       Date:  2014-05       Impact factor: 7.661

6.  Recovery after Nulliparous Birth: A Detailed Analysis of Pain Analgesia and Recovery of Function.

Authors:  Ryu Komatsu; Brendan Carvalho; Pamela D Flood
Journal:  Anesthesiology       Date:  2017-10       Impact factor: 7.892

7.  Filled Prescriptions for Opioids After Vaginal Delivery.

Authors:  Marian Jarlenski; Lisa M Bodnar; Joo Yeon Kim; Julie Donohue; Elizabeth E Krans; Debra L Bogen
Journal:  Obstet Gynecol       Date:  2017-03       Impact factor: 7.661

8.  De facto long-term opioid therapy for noncancer pain.

Authors:  Michael Von Korff; Michael Von Korff; Kathleen Saunders; Gary Thomas Ray; Denise Boudreau; Cynthia Campbell; Joseph Merrill; Mark D Sullivan; Carolyn M Rutter; Michael J Silverberg; Caleb Banta-Green; Constance Weisner
Journal:  Clin J Pain       Date:  2008 Jul-Aug       Impact factor: 3.442

9.  Incidence of and Risk Factors for Chronic Opioid Use Among Opioid-Naive Patients in the Postoperative Period.

Authors:  Eric C Sun; Beth D Darnall; Laurence C Baker; Sean Mackey
Journal:  JAMA Intern Med       Date:  2016-09-01       Impact factor: 44.409

10.  Vital Signs: Changes in Opioid Prescribing in the United States, 2006-2015.

Authors:  Gery P Guy; Kun Zhang; Michele K Bohm; Jan Losby; Brian Lewis; Randall Young; Louise B Murphy; Deborah Dowell
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-07-07       Impact factor: 17.586

View more
  13 in total

1.  Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery.

Authors:  Timothy Nielsen; Dana Bernson; Mishka Terplan; Sarah E Wakeman; Amy M Yule; Pooja K Mehta; Monica Bharel; Hafsatou Diop; Elsie M Taveras; Timothy E Wilens; Davida M Schiff
Journal:  Addiction       Date:  2019-11-13       Impact factor: 6.526

Review 2.  Opioid prescribing after childbirth: overprescribing and chronic use.

Authors:  Sarah S Osmundson; Jea Young Min; Carlos G Grijalva
Journal:  Curr Opin Obstet Gynecol       Date:  2019-04       Impact factor: 1.927

3.  Characterization of neonatal opioid withdrawal syndrome in Arizona from 2010-2017.

Authors:  Emery R Eaves; Jarrett Barber; Ryann Whealy; Sara A Clancey; Rita Wright; Jill Hager Cocking; Joseph Spadafino; Crystal M Hepp
Journal:  PLoS One       Date:  2021-06-03       Impact factor: 3.752

4.  Prescription Opioid Dose After Vaginal Delivery and the Risk of Serious Opioid-Related Events: A Retrospective Cohort Study.

Authors:  Andrew D Wiese; Sarah S Osmundson; Edward Mitchel; Margaret Adgent; Sharon Phillips; Stephen W Patrick; Arlyn Horn; Lauren R Samuels; Marie R Griffin; Carlos G Grijalva
Journal:  Womens Health Issues       Date:  2021-04-15

5.  Patient Experience with Postpartum Pain Management in the Face of the Opioid Crisis.

Authors:  Karolina Leziak; Lynn M Yee; William A Grobman; Nevert Badreldin
Journal:  J Midwifery Womens Health       Date:  2021-03-04       Impact factor: 2.891

6.  Is opioid use safe in women trying to conceive?

Authors:  Kerry S Flannagan; Sunni L Mumford; Lindsey A Sjaarda; Jeannie G Radoc; Neil J Perkins; Victoria C Andriessen; Jessica R Zolton; Robert M Silver; Enrique F Schisterman
Journal:  Epidemiology       Date:  2020-11       Impact factor: 4.860

7.  Antidepressant Use around Conception, Prepregnancy Depression, and Risk of Ectopic Pregnancy.

Authors:  Elizabeth Wall-Wieler; Thalia K Robakis; Carolyn E Cesta; Reem Masarwa; Deirdre J Lyell; Can Liu; Robert W Platt; Suzan L Carmichael
Journal:  Can J Psychiatry       Date:  2020-05-21       Impact factor: 4.356

8.  Benzodiazepine use before conception and risk of ectopic pregnancy.

Authors:  Elizabeth Wall-Wieler; Thalia K Robakis; Deirdre J Lyell; Reem Masarwa; Robert W Platt; Suzan L Carmichael
Journal:  Hum Reprod       Date:  2020-07-01       Impact factor: 6.918

9.  The impact of race on postpartum opioid prescribing practices: a retrospective cohort study.

Authors:  Tyler R McKinnish; Adam K Lewkowitz; Ebony B Carter; Ashley E Veade
Journal:  BMC Pregnancy Childbirth       Date:  2021-06-22       Impact factor: 3.007

10.  Opioid Prescription and Persistent Opioid Use After Ectopic Pregnancy.

Authors:  Elizabeth Wall-Wieler; Chelsea L Shover; Jennifer M Hah; Suzan L Carmichael; Alexander J Butwick
Journal:  Obstet Gynecol       Date:  2020-09       Impact factor: 7.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.